Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, Richard A, Marayati, Raoud, Flate, Elizabeth L, Volmar, Keith E, Loeza, S Gabriela Herrera, Hoadley, Katherine A, Rashid, Naim U, Williams, Lindsay A +10 more·2015·Nature Genetics

DOI 10.1038/ng.3398

Cited by (1,002)

Items 201–300 of 1,002

Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
Maximilian Brunner, Z. Wu, Christian Krautz, Christian P. Pilarsky, Robert Grützmann, Georg F. Weber · 2019 · International Journal of Molecular Sciences
TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer
Mengyu Tu, Lukas Klein, Elisa Espinet, Theodoros Georgomanolis, Florian Wegwitz, Xiaojuan Li, Laura Urbach, Adi Danieli‐Mackay, Stefan Küffer, Kamil Bojarczuk et al. · 2021 · Nature Cancer
Epithelial and stromal co-evolution and complicity in pancreatic cancer
Hingorani, Sunil R. · 2023 · Nature Reviews Cancer
Complete regression of advanced pancreatic ductal adenocarcinomas upon combined inhibition of EGFR and C-RAF
Blasco, María Teresa, Navas, Carolina, Martín-Serrano, Guillermo, Graña-Castro, Osvaldo, Lechuga, Carmen G., Martín-Díaz, Laura, Djurec, Magdolna, Li, Jing, Morales-Cacho, Lucia, Esteban-Burgos, Laura et al. · 2019 · Cancer Cell
Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer
Suhail Yousuf, Mengjie Qiu, Lena Voith von Voithenberg, Johannes Hulkkonen, Igor Mačinković, Axel Ronald Schulz, Domenic Hartmann, Florian Mueller, Margarete Mijatovic, David Ibberson et al. · 2023 · Gastroenterology
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
Yuming Jiang, Zhicheng Zhang, Wei Wang, Weicai Huang, Chuanli Chen, Sujuan Xi, M. Usman Ahmad, Yulan Ren, Shengtian Sang, Jingjing Xie et al. · 2023 · Nature Communications
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
Guangsheng Pei, Jimin Min, Kimal Rajapakshe, Vittorio Branchi, Yunhe Liu, Benson Chellakkan Selvanesan, Fredrik I. Thege, Dorsay Sadeghian, Daiwei Zhang, Kyung Serk Cho et al. · 2025 · Nature
Characterization of spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival
Yohei Masugi, Tokiya Abe, Akihisa Ueno, Yoko Fujii‐Nishimura, Hidenori Ojima, Yutaka Endo, Yusuke Fujita, Minoru Kitago, Masahiro Shinoda, Yuko Kitagawa et al. · 2019 · Modern Pathology
Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence
Franco-Barraza, Janusz, Francescone, Ralph, Luong, Tiffany, Shah, Neelima, Madhani, Raj, Cukierman, Gil, Dulaimi, Essel, Devarajan, Karthik, Egleston, Brian L, Nicolas, Emmanuelle et al. · 2017 · eLife
Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment
Lenka N.C. Boyd, Katarina D. Andini, Godefridus J. Peters, Geert Kazemier M, Elisa Giovannetti · 2021 · Seminars in Cancer Biology
Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells
Markus Breunig, Jessica Merkle, Martin Wagner, Michael Karl Melzer, Thomas F.E. Barth, Thomas Engleitner, Johannes Krumm, Sandra Wiedenmann, Christian M. Cohrs, Lukas Perkhofer et al. · 2021 · Cell stem cell
Advances in the management of pancreatic cancer
Marco Del Chiaro, Toshitaka Sugawara, Sana D. Karam, Wells A. Messersmith · 2023 · BMJ
Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer
Elisa Giovannetti, Carolien L. van der Borden, Adam Enver Frampton, Asif Ali, Omidreza Firuzi, Godefridus J. Peters · 2017 · Seminars in Cancer Biology
Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer
Jesper B. Bramsen, Mads Heilskov Rasmussen, Halit Ongen, Trine Block Mattesen, Mai‐Britt W. Ørntoft, Sigrid S. Árnadóttir, Juan Sandoval, Teresa Laguna, Søren Vang, Bodil Øster et al. · 2017 · Cell Reports
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
Koay, Eugene J., Lee, Yeonju, Cristini, Vittorio, Lowengrub, John S., Kang, Ya'an, Lucas, F. Anthony San, Hobbs, Brian P., Ye, Rong, Elganainy, Dalia, Almahariq, Muayad et al. · 2018 · Clinical Cancer Research
Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches
Truong, Linh-Huyen, Pauklin, Siim · 2021 · Cancers
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Kano, Yoshihito, Gebregiworgis, Teklab, Marshall, Christopher B., Radulovich, Nikolina, Poon, Betty P. K., St-Germain, Jonathan, Cook, Jonathan D., Valencia-Sama, Ivette, Grant, Benjamin M. M., Herrera, Silvia Gabriela et al. · 2019 · Nature Communications
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Anna M. Varghese, Maria Perry, Joanne F. Chou, Subhiksha Nandakumar, Daniel M. Muldoon, Amanda Erakky, Amanda Zucker, Christopher John Fong, Miika M. Mehine, Bastien Nguyen et al. · 2025 · Nature Medicine
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3
Rachel Hesler, Jennifer Jing Huang, Mark D. Starr, Victoria M. Treboschi, Alyssa Bernanke, Andrew B. Nixon, Shannon J. McCall, Rebekah Ruth White, Gerard C. Blobe · 2016 · Carcinogenesis
Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma
Nadine Sperb, Miltiadis Tsesmelis, Thomas Wirth · 2020 · International Journal of Molecular Sciences
Pancreatic cancer subtypes: a roadmap for precision medicine
Torres, Carolina, Grippo, Paul J. · 2018 · Annals of Medicine
Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment
Hiroyoshi Y. Tanaka, Mitsunobu R. Kano · 2018 · Cancer Science
Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
Gwen Alyce Lomberk, Nelson Dusetti, Juan Iovanna, Raul A. Urrutia · 2019 · Nature Communications
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program
Michael Jon Pishvaian, Edik Matthew Blais, Jonathan Robert Brody, Lola Rahib, Emily E. Lyons, Patricia Arbeloa, Andrew Eugene Hendifar, Sameh Mikhail, Vincent M. Chung, Davendra P. S. Sohal et al. · 2019 · JCO Precision Oncology
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma
Liu, Hao, Naxerova, Kamila, Pinter, Matthias, Incio, Joao, Lee, Hang, Shigeta, Kohei, Ho, William W., Crain, Jonathan A., Jacobson, Alex, Michelakos, Theodoros et al. · 2017 · Clinical Cancer Research
Tumor-associated macrophages in pancreatic ductal adenocarcinoma: therapeutic opportunities and clinical challenges
Poh, Ashleigh R., Ernst, Matthias · 2021 · Cancers
Tumor Heterogeneity in Pancreatic Adenocarcinoma
Jerome F. Cros, Jérôme Raffenne, Anne Couvelard, Nicolas Poté · 2017 · Pathobiology
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
Stefanie Bärthel, Chiara Falcomatà, Roland Rad, Fabian Joachim Theis, Dieter Saur · 2023 · Nature Cancer
Pancreatic cancer: Current research and future directions
Marco Falasca, Minkyoung Kim, Ilaria Casari · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility
Erik S. Knudsen, Uthra Balaji, Brian K. Mannakee, Paris J. Vail, Cody R. Eslinger, Christopher Moxom, John C. Mansour, Agnieszka Katarzyna Witkiewicz · 2017 · Gut
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Alexander Biederstädt, Zonera Hassan, Christian Schneeweis, Markus Schick, Lara Schneider, Alexander Muckenhuber, Ying‐Fen Hong, Gerrit Siegers, Lisa M. Nilsson, Matthias Wirth et al. · 2020 · Gut
Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity
Xiaohan Shi, Yunguang Li, Qiuyue Yuan, Shijie Tang, Shiwei Guo, Yehan Zhang, Juan He, Xiaoyu Zhang, Ming Han, Zhuang Liu et al. · 2022 · Nature Communications
Force-dependent breaching of the basement membrane
Tammy T. Chang, Dhruv Thakar, Valerie Marie Weaver · 2016 · Matrix Biology
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
Musalula Sinkala, Nicola Mulder, Darren Patrick Martin · 2020 · Scientific Reports
FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
Sonia Zaghdoudi, Emilie Decaup, Ismahane Belhabib, Rémi Samain, Stéphanie Cassant‐Sourdy, Julia Rochotte, Alexia Brunel, David D. Schlaepfer, Jerome F. Cros, Cindy Neuzillet et al. · 2020 · EMBO Molecular Medicine
MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma
Ravikanth Maddipati, Robert J. Norgard, Timour Baslan, Komal S. Rathi, Amy Xin Wei Zhang, Asal Saeid, Taku Higashihara, Feng Wu, Angad Kumar, Valli Annamalai et al. · 2021 · Cancer Discovery
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity
Hannah L. Williams, Andressa Dias Costa, Jinming Zhang, Srivatsan Raghavan, Peter S. Winter, Kevin S. Kapner, Scott P. Ginebaugh, Sara A. Väyrynen, Juha P. Väyrynen, Chen Yuan et al. · 2022 · Cancer Research
Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer
Vidhi M. Shah, Brett C. Sheppard, Rosalie C. Sears, Adam W. G. Alani · 2020 · Cancer Letters
Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen
Yurina Ogawa, Yohei Masugi, Tokiya Abe, Ken Yamazaki, Akihisa Ueno, Yoko Fujii‐Nishimura, Shutaro Hori, Hiroshi Yagi, Abe Yuta, Minoru Kitago et al. · 2020 · Clinical Cancer Research
USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
Hou, Pingping, Ma, Xingdi, Zhang, Qiang, Wu, Chang-Jiun, Liao, Wenting, Li, Jun, Wang, Huamin, Zhao, Jun, Zhou, Xin, Guan, Carolyn et al. · 2019 · Genes & Development
Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types
Je‐Keun Rhee, Yu Chae Jung, Kyu Ryung Kim, Jinseon Yoo, Jeeyoon Kim, Yongjae Lee, Yoon Ho Ko, Han Hong Lee, Byoung Chul Cho, Tae‐Min Kim · 2017 · Cancer Immunology Research
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
Sreenivasa Rao Chandana, Hani M. Babiker, Daruka Mahadevan · 2018 · Expert Opinion on Investigational Drugs
DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network
Feda H. Hamdan, Steven A. Johnsen · 2018 · Proceedings of the National Academy of Sciences
Single-cell RNA-seq analysis identifies markers of resistance to targeted BRAF inhibitors in melanoma cell populations
Yu-Jui Ho, Naishitha Anaparthy, David C. Molik, Grinu Mathew, Toby P. Aicher, Ami K. Patel, James B Hicks, Molly Hammell · 2018 · Genome Research
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
James R. W. Conway, David Herrmann, TR Jeffry Evans, Jennifer P. Morton, Paul Timpson · 2018 · Gut
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
Amina Jbara, Kuan‐Ting Lin, Chani Stossel, Zahava Siegfried, Haya Shqerat, Adi Amar-Schwartz, Ela Elyada, Maxim Mogilevsky, Maria Raitses‐Gurevich, Jared Lee Johnson et al. · 2023 · Nature
A developmental constraint model of cancer cell states and tumor heterogeneity
Ayushi S. Patel, Itai Yanai · 2024 · Cell
Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment
Carina Shiau, Jingyi Cao, Dennis H. Gong, Mark Gregory, Nicholas J Caldwell, Xunqin Yin, Jae-Won Cho, Peter L. Wang, Jennifer Su, Steven Wang et al. · 2024 · Nature Genetics
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Kumar Narang, Jing He, Christopher L. Wolfgang, Keyu Li, Lei Zheng · 2024 · Journal of Hematology & Oncology
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Bolun Jiang, Li Zhou, Jun Lü, Yizhi Wang, Chengxi Liu, Lei You, Junchao Guo · 2020 · Frontiers in Oncology
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
Birte Kulemann, Stephanie Rösch, Sindy Seifert, Sylvia Timme, Peter Bronsert, Gabriel J. Seifert, Verena Martini, Jasmina Kuvendjiska, Torben Glatz, Saskia Hussung et al. · 2017 · Scientific Reports
DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
Jeroni Luna, Jacopo Boni, Míriam Cuatrecasas, Xavier Bofill‐De Ros, Estela Núñez-Manchón, Meritxell Gironella, Eva Cristina Vaquero, Maria Lourdes Arbonés, Susana de la Luna, Cristina Fillat · 2018 · Gut
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses
Yu‐Pei Chen, Jia‐Wei Lv, Yan‐Ping Mao, Xiaomin Li, Junyan Li, Yaqin Wang, Cheng Xu, Ying‐Qin Li, Qing‐Mei He, Xiaojing Yang et al. · 2021 · Molecular Cancer
Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes
Premila Devi Leiphrakpam, Sanjib Chowdhury, Michelle H. Zhang, Varnica Bajaj, Mashaal Dhir, Chandrakanth Are · 2025 · Journal of Gastrointestinal Cancer
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response
Alexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, Katja Steiger, Björn Konukiewitz, Andreas Trumpp, Roland Eils, Jens Werner, Helmut Friess, Iréne Esposito et al. · 2017 · Clinical Cancer Research
Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors
David Jérémie Birnbaum, François Bertucci, Pascal Finetti, Daniel Birnbaum, Émilie Mamessier · 2019 · Cancers
Prognostic and predictive factors in pancreatic cancer
Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola et al. · 2020 · Oncotarget
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
Rémy Nicolle, Yuna Blum, Pauline Duconseil, Charles Vanbrugghe, Nicolas Brandone, Flora Poizat, Julie Roques, Martin Bigonnet, Odile Gayet, Marion Rubis et al. · 2020 · EBioMedicine
Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
Xing Huang, Gang Zhang, Tianyu Tang, Xiang Gao, Tingbo Liang · 2022 · Military Medical Research
New therapeutic targets in pancreatic cancer
Eleonora Lai, Marco Puzzoni, Pina Ziranu, Andrea Pretta, Valentino Impera, Stefano Mariani, Nicole Liscia, Paolo Soro, Francesca Musio, Mara Persano et al. · 2019 · Cancer Treatment Reviews
Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression
Salina Yuan, Ramakrishnan Natesan, Francisco J. Sánchez Rivera, Jinyang Li, Natarajan V. Bhanu, Taiji Yamazoe, Jeffrey Lin, Allyson J. Merrell, Yogev Sela, Stacy K. Thomas et al. · 2020 · Cancer Discovery
Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment
Steve Robatel, Mirjam Schenk · 2022 · Cancers
Genetics of familial and sporadic pancreatic cancer
Wood, Laura D., Yurgelun, Matthew B., Goggins, Michael G. · 2019 · Gastroenterology
Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions
Bing Ren, Xiaoying Liu, Arief Antonius Suriawinata · 2018 · American Journal Of Pathology
TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development
Mei Yi, Yi-Xin Tan, Li Wang, Jing Cai, Xiao-Ling Li, Zhao-Yang Zeng, W. Xiong, Gui-Yuan Li, Xia-Yu Li, Pingqing Tan et al. · 2020 · Cellular and Molecular Life Sciences
Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma
Robert J. Torphy, Zhen Wang, Aisha True‐Yasaki, Keith E. Volmar, Naim U. Rashid, Benjamin M. Yeh, Julia Sidenius Johansen, Michael Anthony Hollingsworth, Jen Jen Yeh, Eric Andrew Collisson · 2018 · JCO Precision Oncology
A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer
Bernhard Kloesch, Vivien S. Ionasz, Sumit Paliwal, Natascha Hruschka, Jaime Martínez de Villarreal, Rupert Öllinger, Sebastian Mueller, Hans Peter Dienes, Martin Schindl, Elisabeth S. Gruber et al. · 2021 · Gut
Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer
Julienne L. Carstens, Sujuan Yang, Pedro Corrêa de Sampaio, Xiaofeng Zheng, Souptik Barua, Kathleen M. McAndrews, Arvind U.K. Rao, Jared K. Burks, Andrew D. Rhim, Raghu Kalluri · 2021 · Cell Reports
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer
Christina R Adams, Htet Htwe Htwe, Timothy Marsh, Aprilgate L Wang, Megan L. Montoya, Lakshmipriya Subbaraj, Aaron D. Tward, Nabeel M. Bardeesy, Rushika M. Perera · 2019 · eLife
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
Joseph Wang Franses, Julia Philipp, Pavlos Missios, Irun Bhan, Ann Liu, Chittampalli N. Yashaswini, Eric C. Tai, Huili Zhu, Matteo Ligorio, Benjamin Nicholson et al. · 2020 · Nature Communications
Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies
Tessa Y. S. Le Large, Maarten F. Bijlsma, Geert Kazemier M, Hanneke W.M. van Laarhoven, Elisa Giovannetti, Connie R. Jiménez · 2017 · Seminars in Cancer Biology
Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation
Tim D.D. Somerville, Giulia Biffi, Juliane Daßler‐Plenker, Stella K. Hur, Xue‐Yan He, Krysten E. Vance, Koji Miyabayashi, Yali Xu, Diogo Maia-Silva, Olaf Klingbeil et al. · 2020 · eLife
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Meredith L. Stone, Gregory Lawrence Beatty · 2019 · Pharmacology & Therapeutics
Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer
Xiaoyu Liu, Lingxiao Liu, Yuan Ji, Changyu Li, Tao Wei, Xuerong Yang, Yuefang Zhang, Xuyu Cai, Ting Yang, Yangbin Gao et al. · 2019 · EBioMedicine
CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness
Jérémy Nigri, Julie Leca, Sarah-Simha Tubiana, Pascal Finetti, Fabienne Guillaumond, Sébastien Martinez, Sophie Lac, Juan Iovanna, Stéphane Audebert, Luc Camoin et al. · 2022 · Science Signaling
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Lan Zhao, Hongya Zhao, Hong Yan · 2018 · BMC Cancer
Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome
Wenjie Huang, Bernat Navarro-Serer, Yea Ji Jeong, Peter E. Chianchiano, Limin Xia, Claudio Luchini, Nicola Veronese, Cameron Dowiak, Tammy Ng, María Aurora Martínez Trujillo et al. · 2020 · Cancer Research
Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer
Lucia Roa‐Peña, Cindy V. Leiton, Sruthi Babu, Chun‐Hao Pan, Elizabeth A. Vanner, Ali Akalin, Jela Bandovic, Richard A. Moffitt, Kenneth Reed Shroyer, Luisa F. Escobar‐Hoyos · 2019 · Scientific Reports
Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling
Élodie Roger, Sylvie Martel, Adrien Bertrand‐Chapel, Arnaud Depollier, Nicolas Chuvin, Roxane M. Pommier, Karam Yacoub, Cassandre Caligaris, Victoire Cardot‐Ruffino, Véronique Chauvet et al. · 2019 · Cell Death and Disease
Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit
Bailiang Li, Yuming Jiang, Guoxin Li, George Albert Fisher, Ruijiang Li · 2020 · JCI Insight
Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology
Karin Feldmann, H. Carlo Maurer, Katja Peschke, Steffen Teller, Kathleen Schuck, Katja Steiger, Thomas Engleitner, Rupert Öllinger, Alice Nomura, Nils Wirges et al. · 2020 · Gastroenterology
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer
Singhal, Anupriya, Styers, Hannah C., Rub, Jonathan, Li, Zhuxuan, Torborg, Stefan R., Kim, Jung Yun, Grbovic-Huezo, Olivera, Feng, Huijin, Tarcan, Zeynep Cagla, Sahin Ozkan, Hulya et al. · 2024 · Cancer Discovery
The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice
Prasad R. Dandawate, Chandrayee Ghosh, Kanagaraj Palaniyandi, Santanu Paul, Sonia Rawal, Rohan Pradhan, Afreen Asif Ali Sayed, Sonali Choudhury, David Standing, Dharmalingam Subramaniam et al. · 2019 · Gastroenterology
A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS
Xiaohua Duan, Tuo Zhang, Lingling Feng, Neranjan de Silva, Benjamin C. Greenspun, Xing Wang, Jenna E. Moyer, M. Laura Martin, Rohit Chandwani, Olivier Elemento et al. · 2023 · Cell stem cell
ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer
Huang, Yun-Han, Hu, Jing, Chen, Fei, Lecomte, Nicolas, Basnet, Harihar, David, Charles J., Witkin, Matthew D., Allen, Peter J., Leach, Steven D., Hollmann, Travis J. et al. · 2020 · Cancer Discovery
Pancreatic cancer survival analysis defines a signature that predicts outcome
Pichai Raman, Ravikanth Maddipati, Kian‐Huat Lim, Aydın Tözeren · 2018 · PLoS ONE
Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype
Ki Oh, Yun Jae Yoo, Luke A. Torre-Healy, Manisha Rao, Danielle Fassler, Pei Wang, Michael D. Caponegro, Mei Gao, Joseph Kim, Aaron R. Sasson et al. · 2023 · Nature Communications
Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
Keisuke Yamamoto, Keisuke Tateishi, Yotaro Kudo, Mayumi Hoshikawa, Mariko Hori Tanaka, Takuma Nakatsuka, Hiroaki Fujiwara, Koji Miyabayashi, Ryota Takahashi, Yasuo Tanaka et al. · 2016 · Oncotarget
Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems
Frederike Dijk, Veronique L. Veenstra, Eline C. Soer, Mark P.G. Dings, Lan Zhao, Johannes B.G. Halfwerk, Gerrit K. J. Hooijer, Helene Damhofer, Marco Marzano, Anne Steins et al. · 2020 · Scientific Reports
Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion
Elizabeth R. Murray, Shinelle Menezes, Jack C. Henry, Josie L. Williams, Lorena Alba‐Castellón, Priththivika Baskaran, Ivan Quétier, Ami Desai, Jacqueline J. T. Marshall, Ian R. Rosewell et al. · 2022 · Cell Reports
GREM1 is required to maintain cellular heterogeneity in pancreatic cancer
Linxiang Lan, Theodore Evan, Huafu Li, Aasia Hussain, E. Josue Ruiz, May Zaw Thin, Rute M. M. Ferreira, Hari PS, Eva Madi Riising, Yoh Zen et al. · 2022 · Nature
FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer
Marta Canel, Aleksandra Sławińska, David W. Lonergan, Ashwin Adrian Kallor, Rosanna Upstill‐Goddard, Catherine Davidson, Alex von Kriegsheim, Andrew Victor Biankin, Adam Byron, Javier A. Alfaro et al. · 2023 · Gut
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis
Tianxing Zhou, Yongjie Xie, Xupeng Hou, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan et al. · 2023 · Journal of Experimental & Clinical Cancer Research
Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
Luo Qi, Andrew Erich Teschendorff · 2022 · Clinical Epigenetics
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
Marta Alonso‐Nocelo, Laura Ruíz-Cañas, Patricia Sancho, Kıvanç Görgülü, Sonia Alcalá, Coral Pedrero, Mireia Vallespinós, Juan Carlos López-Gil, Marina Ochando, Elena García-García et al. · 2022 · Gut
Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer
Yunguang Li, Shijie Tang, Xiaohan Shi, Jingwen Lv, Xueyuan Wu, Yehan Zhang, Huan Wang, Juan He, Yiqin Zhu, Yi Ju et al. · 2023 · Cell Reports Medicine
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, Lena Dreikhausen, Michael Hirth, Moying Li, Philip Weidner, Antonia Leipertz, Andreas Teufel, Matthias P A Ebert · 2025 · Signal Transduction and Targeted Therapy
Patient-derived xenograft models of pancreatic cancer: overview and comparison with other types of models
Garcia, Patrick L., Miller, Aubrey L., Yoon, Karina J. · 2020 · Cancers
Organoid models for translational pancreatic cancer research
Hervé Tiriac, Dennis Plenker, Lindsey A. Baker, David A. Tuveson · 2019 · Current Opinion in Genetics & Development
Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
Shinelle Menezes, Mohamed Hazem Okail, Siti Munira Abd Jalil, Hemant Mahendrakumar Kocher, Angus J.M. Cameron · 2022 · The Journal of Pathology